ASIA unversity:Item 310904400/108252
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 94286/110023 (86%)
造访人次 : 21693511      在线人数 : 583
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/108252


    题名: Female schizophrenia patients and risk of breast cancer: A population-based cohort study.
    作者: Ana IsabelWu;Ana IsabelWu Chou;Yu-Chiao Wang;Cheng-Li Lin;高嘉鴻;Chia-Hung Kao
    贡献者: 生物資訊與醫學工程學系
    日期: 2017-10
    上传时间: 2017-11-03 06:04:42 (UTC+0)
    摘要: Objective
    Breast cancer is the most common type of cancer in women. This population-based cohort study aimed to examine the association between breast cancer in female schizophrenia patients and its association with the use of antipsychotics drugs.

    Methods
    All study subjects were selected from the Taiwan Insurance Claims Data (1998–2008). We compared the risk for breast cancer between female schizophrenia patients receiving antipsychotics (n = 29,641) with female patients without any serious mental illnesses nor receiving antipsychotic drugs (n = 59,282). We also compared between patients on 1) first-generation antipsychotics (FGAs) alone; 2) combination of first and second generation antipsychotics (SGAs); and 3) SGAs alone. We then stratified those on SGAs into two subgroups according to their prolactin-elevating properties: risperidone (RIS), paliperidone (PAL) or amisulpride (AMI) and all other SGAs.

    Results
    After adjusting for confounding factors, the risk of breast cancer in female schizophrenia patients was 1.94 higher than the non-schizophrenia cohort (aHR: 1.94, 95% CI: 1.43–2.63). Schizophrenia patients receiving a combination of FGAs and SGAs had a slightly higher risk of breast cancer than non-schizophrenic patients (aHR: 2.17, 95% CI: 1.56–3.01). Patients on RIS, PAL, and AMI had a 1.96-fold risk of breast cancer compared to the non-schizophrenic cohort (95% CI: 1.36–2.82).

    Conclusions
    This study raises awareness among both clinicians and patients about the importance of breast cancer screening and the promotion of healthy lifestyle choices. Due to the nature of our database, confounding factors – such as parity, obesity, hormone therapy, and smoking - could not be controlled for.
    關聯: SCHIZOPHRENIA RESEARCH
    显示于类别:[生物資訊與醫學工程學系 ] 期刊論文

    文件中的档案:

    档案 大小格式浏览次数
    index.html0KbHTML337检视/开启


    在ASIAIR中所有的数据项都受到原著作权保护.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈